跳至主要内容
临床试验/JPRN-UMIN000049168
JPRN-UMIN000049168已完成Unknown

Analysis of additional granulocyte and monocyte adsorption therapy for incomplete remission induction in ulcerative colitis - Additional treatment with GMA in UC

Dokkyo Medical University School of Medicine0 个研究点目标入组 194 人开始时间: 2022年10月9日最近更新:
适应症

试验速览

阶段
Unknown
状态
已完成
发起方
入组人数
194

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients who oral administration adherence is less than 80%. Patients who did not complete granulocyte/monocyte adsorption because of vascular securing difficulty. Patients who treated with granulocyte/monocyte adsorption monotherapy.

研究者

发起方
Dokkyo Medical University School of Medicine

相似试验

已完成
不适用
The study of the combination effect of granulocyte/monocyte adsorptive apheresis in Crohn's disease patients who lose response to Infliximab therapyCrohn's disease
JPRN-UMIN000035185Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University10
招募中
不适用
Therapeutic effect of granulocyte and monocyte adsorption column (Adacolumn) for refractory skin diseasesInflammatory keratosis (psoriasis vulgaris, psoriasis arthropica), neutrophilic dermatosis (pustular psoriasis, palmoplantar pustulosis, Behcet disease, Sweet disease, gangrene pyoderma, erythema elevatum diutinum) , vasculitis syndrome (nodular arteritis, cutaneous allergic vasculitis, Schonlein-Henoch purpura, Wegener&#39s granulomatosis), eosinophilic disease (hypereosinophilic syndrome, atopic dermatitis), etc
JPRN-UMIN000021070Kagoshima University60
已完成
2 期
Evaluation the effect of Granulocyte Colony Stimulating Factor on infertilityinfertility.Female infertility, unspecifiedN97.9
IRCT20200303046688N1Bandare-abbas University of Medical Sciences88
招募中
不适用
Efficacy of Intensive Granulocyte and Monocyte Apheresis in Patients with PouchitisPouchitis
JPRN-UMIN000010207Faculty of Medicine, University of Tokyo20
已完成
不适用
Prospective randomised comparison of granulocyte colony-stimulating factor (G-CSF) (filgrastim) secondary prophylaxis versus conservative management of chemotherapy-induced neutropenia to maintain dose intensity in chemotherapy for breast cancerBreastCancer
ISRCTN89698860Anglo Celtic Cooperative Oncology Group (UK)400